Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cornerstone Equity Investors is a private equity firm that specializes in middle-market buyouts and growth equity investments, with a historical emphasis on the healthcare sector. Founded in 1996 as a spin-out from Prudential Equity Investors, the firm has managed over $1.2 billion in committed capital across multiple funds. Their investment strategy focused on sectors such as healthcare services, medical products, specialty pharmaceuticals, and business services. The firm typically targeted companies with strong management teams and clear paths for operational improvement or market consolidation. Notable healthcare-related investments in their portfolio have included Centene Corporation, Team Health, and Health Management Associates. While the firm was a prominent player in the late 1990s and early 2000s, it is currently considered a legacy investment firm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cornerstone Equity Investors.